Rocuronium Bromide Injection
Product Images NDC 0143-9251

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Rocuronium Bromide (NDC 0143-9251). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hikma Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Rocuronium Bromide Chemical Structure (Rocuronium Bromide Injection 1)

Chemical structure of Rocuronium Bromide showing its steroidal backbone with an acetate group, hydroxy group, quaternary ammonium, and bromide ion. This diagram illustrates the molecular arrangement of the active ingredient Rocuronium Bromide.*

FDA Label Image

Rocuronium Bromide Injection 10

Label panel displaying a QR code along with product identification details for Rocuronium Bromide 10 mg/mL injection by Hikma Pharmaceuticals USA Inc. The label includes a GTIN, serial number (SN), expiration date (EXP), and lot number (LOT) in alphanumeric format.*

FDA Label Image

Figure 1: Time To 80% Or Greater Block Vs. Initial Dose Of Rocuronium Bromide By Age Group (median, 25th And 75th Percentile, And Individual Values) (Rocuronium Bromide Injection 2)

A scatter plot with box plots comparing minutes on the y-axis versus dosage in mg/kg on the x-axis, grouped by age ranges: 18-64 years, 65 and older, and 1-12 years. The graph shows variation in data points and distributions across dosages and age groups.*

FDA Label Image

Figure 2: Duration Of Clinical Effect Vs. Initial Dose Of Rocuronium Bromide By Age Group (median, 25th And 75th Percentile, And Individual Values) (Rocuronium Bromide Injection 3)

A scatter and box plot chart comparing a variable measured in minutes across different age groups and dosages of Rocuronium Bromide. The x-axis shows dosage levels (mg/kg) by age categories (18-64 years, 65 years and older, 3 months to 1 year, and 1 to 12 years), and the y-axis shows time in minutes, illustrating variability and medians within each group.*

FDA Label Image

Figure 3: Duration Of Clinical Effect Vs. Number Of Rocuronium Bromide Maintenance Doses, By Dose (Rocuronium Bromide Injection 4)

A line graph depicting the time in minutes on the vertical axis and dose number on the horizontal axis. It compares two dosages, 0.10 mg/kg and 0.15 mg/kg, with sample sizes of 29 and 13 respectively, showing changes in a measured parameter over five doses.*

FDA Label Image

Plb035-wes.2 (Rocuronium Bromide Injection 5)

Rocuronium Bromide Injection 10 mg/mL label for a 5 mL multiple-dose vial. The label indicates the dosage strength as 50 mg per 5 mL, identifies the drug as a paralyzing agent for intravenous use only, and lists Hikma Pharmaceuticals USA Inc. as the labeler. The label includes warnings, lot number, and expiration date fields.*

FDA Label Image

Plb036/wes.2 (Rocuronium Bromide Injection 6)

Rocuronium Bromide Injection label showing 50 mg per 5 mL (10 mg/mL) intravenous dosage form by Hikma Pharmaceuticals USA Inc. The label includes a barcode, warnings about paralysis and respiratory arrest, storage instructions, and states the product is sterile and nonpyrogenic. It is presented as 10 x 5 mL multiple dose vials for hospital or clinical use.*

FDA Label Image

Rocuronium Bromide Injection 7

Label of Rocuronium Bromide Injection 10 mg/mL, a human prescription drug for intravenous use. The label prominently shows the drug name, strength, and administration route, with a warning indicating it is a paralyzing agent. The labeler is Hikma Pharmaceuticals USA Inc.*

FDA Label Image

Rocuronium Bromide Injection 8

Rocuronium Bromide 100 mg per 10 mL (10 mg/mL) injection label for intravenous use. The label includes the proprietary and generic name, strength, and usage warning 'Paralyzing Agent.' The product is single-dose vial (10 mL) and manufactured by Hikma Pharmaceuticals USA Inc. Additional text includes directions and caution statements.*

FDA Label Image

Rocuronium Bromide Injection 9

Rocuronium Bromide Injection 100 mg per 10 mL (10 mg/mL) in multiple-dose vials, labeled for intravenous use. The label includes warnings about respiratory arrest and the necessity for artificial respiration facilities. The product is manufactured by Hikma Pharmaceuticals USA Inc. and distributed by Riviera Pharmaceuticals USA, Inc.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.